|
Great Britain
|
Advantage 40 Spot-on Solution for Dogs
|
Elanco GmbH
|
52127/5142
|
|
|
NFA-VPS
|
View aligned product details
|
|
Northern Ireland
|
Advantage 40 Spot-on Solution for Dogs
|
Elanco GmbH
|
52127/3067
|
|
|
NFA-VPS
|
View aligned product details
|
|
Great Britain
|
Advantage 400 mg Spot-on Solution for Extra Large Dogs
|
Elanco GmbH
|
52127/5159
|
|
|
AVM-GSL
|
View aligned product details
|
|
Northern Ireland
|
Advantage 400 mg Spot-on Solution for Extra Large Dogs
|
Elanco GmbH
|
52127/3084
|
|
|
AVM-GSL
|
View aligned product details
|
|
Great Britain
|
Advantage 400 Spot-on Solution for Dogs
|
Elanco GmbH
|
52127/5143
|
|
|
NFA-VPS
|
View aligned product details
|
|
Northern Ireland
|
Advantage 400 Spot-on Solution for Dogs
|
Elanco GmbH
|
52127/3068
|
|
|
NFA-VPS
|
View aligned product details
|
|
Northern Ireland
|
Advantage 80 mg Spot-on Solution for Cats ((≥ 4 kg)
|
Elanco GmbH
|
52127/3060
|
|
|
NFA-VPS
|
View aligned product details
|
|
Great Britain
|
Advantage 80 mg Spot-on Solution for Cats (≥ 4 kg)
|
Elanco GmbH
|
52127/5135
|
|
|
NFA-VPS
|
View aligned product details
|
|
Great Britain
|
Advantage 80 mg Spot-on Solution for Large Cats and Pet Rabbits
|
Elanco GmbH
|
52127/5150
|
|
|
AVM-GSL
|
View aligned product details
|
|
Northern Ireland
|
Advantage 80 mg Spot-on Solution for Large Cats and Pet Rabbits
|
Elanco GmbH
|
52127/3075
|
|
|
AVM-GSL
|
View aligned product details
|
|
Great Britain
|
Advantage Chewable 112 mg Chewable Tablets for Dogs
(>2.5–5.5 kg)
|
Elanco GmbH
|
52127/5047
|
|
|
NFA-VPS
|
|
|
Great Britain
|
Advantage Chewable 225 mg Chewable Tablets for Dogs
(>5.5–11 kg)
|
Elanco GmbH
|
52127/5048
|
|
|
NFA-VPS
|
|
|
Great Britain
|
Advantage Chewable 450 mg Chewable Tablets for Dogs
(>11–22 kg)
|
Elanco GmbH
|
52127/5049
|
|
|
NFA-VPS
|
|
|
Great Britain
|
Advantage Chewable 56 mg Chewable Tablets for Dogs
(1.3–2.5 kg)
|
Elanco GmbH
|
52127/5046
|
|
|
NFA-VPS
|
|
|
Great Britain
|
Advantage Chewable 900 mg Chewable Tablets for Dogs
(>22–45 kg)
|
Elanco GmbH
|
52127/5050
|
|
|
NFA-VPS
|
|
|
Northern Ireland
|
Advantix 100 mg + 500 mg Spot-on Solution for Dogs (> 4 kg ≤ 10 kg)
|
Elanco GmbH
|
52127/3048
|
-
Imidacloprid
-
Permethrin (Cis:Trans 40:60)
|
|
POM-V
|
View aligned product details
|
|
Great Britain
|
Advantix 100 mg + 500 mg Spot-on Solution for Dogs (> 4 kg ≤ 10 kg)
|
Elanco GmbH
|
52127/5123
|
-
Imidacloprid
-
Permethrin (Cis:Trans 40:60)
|
|
POM-V
|
View aligned product details
|
|
Great Britain
|
Advantix 250 mg + 1250 mg Spot-on Solution for Dogs (> 10 kg ≤ 25 kg)
|
Elanco GmbH
|
52127/5124
|
-
Imidacloprid
-
Permethrin (Cis:Trans 40:60)
|
|
POM-V
|
View aligned product details
|
|
Northern Ireland
|
Advantix 250 mg + 1250 mg Spot-on Solution for Dogs (> 10 kg ≤ 25 kg)
|
Elanco GmbH
|
52127/3049
|
-
Imidacloprid
-
Permethrin (Cis:Trans 40:60)
|
|
POM-V
|
View aligned product details
|
|
Northern Ireland
|
Advantix 40 mg + 200 mg Spot-on Solution for Dogs (≤ 4 kg)
|
Elanco GmbH
|
52127/3050
|
-
Imidacloprid
-
Permethrin (Cis:Trans 40:60)
|
|
POM-V
|
View aligned product details
|